Ogasawara Kenichi, Sano Rie, Kominato Yoshihiko
Department of Research and Development, Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
Department of Forensic Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
Transfus Med Hemother. 2024 Mar 12;51(4):210-224. doi: 10.1159/000536556. eCollection 2024 Aug.
We review the transcriptional regulation of expression and discuss variants in the promoter and erythroid cell-specific regulatory region in individuals with weak ABO phenotypes such as B, A, B, and A. We also review the molecular mechanisms responsible for variations in expression in development and disease including the cell type-specific expression of during erythroid cell differentiation, and reduction of A- or B-antigens in cancer cells or on red blood cells in patients with leukemia. Although the relationship between ABO blood group antigens and diseases has been characterized, the physiological significance of the ABO blood group system remains unclear.
This review discusses accumulated knowledge of the gene regulation and potential reasons for conservation of ABO during evolution.
我们回顾了ABO表达的转录调控,并讨论了弱ABO血型表型个体(如Bw、Aw、Bx和Ax)启动子和红系细胞特异性调控区域的变异。我们还回顾了发育和疾病中ABO表达变异的分子机制,包括红系细胞分化过程中ABO的细胞类型特异性表达,以及白血病患者癌细胞或红细胞上A或B抗原的减少。尽管ABO血型抗原与疾病之间的关系已得到表征,但ABO血型系统的生理意义仍不清楚。
本综述讨论了ABO基因调控的累积知识以及ABO在进化过程中保守的潜在原因。